Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;119:2886-2893
Published online before print May 26, 2009, doi: 10.1161/CIRCULATIONAHA.108.837369
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
119/22/2886    most recent
CIRCULATIONAHA.108.837369v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Pop-Busui, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pop-Busui, R.
Related Collections
Right arrow Electrophysiology
Right arrow Type 1 diabetes
Right arrow Other Treatment
Right arrow Other diagnostic testing
Right arrow Epidemiology
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrowRelated Articles

(Circulation. 2009;119:2886-2893.)
© 2009 American Heart Association, Inc.


Epidemiology

Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus

The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC)

Rodica Pop-Busui, MD, PhD; Phillip A. Low, MD; Barbara H. Waberski, MS; Catherine L. Martin, MS; James W. Albers, MD, PhD; Eva L. Feldman, MD, PhD; Catherine Sommer; Patricia A. Cleary, MS; John M. Lachin, ScD; William H. Herman, MD, MPH, for the DCCT/EDIC Research Group

From the University of Michigan, Departments of Internal Medicine, Division of Metabolism, Endocrinology, Diabetes (R.P.-B., C.L.M., W.H.H.), and Neurology (J.W.A., E.L.F.), Ann Arbor; Mayo Clinic, Department of Neurology, Rochester, Minn (P.A.L., C.S.); and The Biostatistics Center, George Washington University, Rockville, Md (B.H.W., P.A.C., J.M.L.).

Correspondence to Rodica Pop-Busui, MD, PhD, 5570 D MSRB 2, 1150 W Medical Center Dr, Ann Arbor, MI 48109. E-mail rpbusui{at}umich.edu

Received November 21, 2008; accepted March 20, 2009.

Background— The Epidemiology of Diabetes Interventions and Complications (EDIC) study, a prospective observational follow-up of the Diabetes Control and Complications Trial (DCCT) cohort, reported persistent benefit of prior intensive therapy on retinopathy and nephropathy in type 1 diabetes mellitus. We evaluated the effects of prior intensive insulin therapy on the prevalence and incidence of cardiac autonomic neuropathy (CAN) in former DCCT intensive and conventional therapy subjects 13 to 14 years after DCCT closeout.

Methods and Results— DCCT autonomic measures (R-R variation with paced breathing, Valsalva ratio, postural blood pressure changes, and autonomic symptoms) were repeated in 1226 EDIC subjects in EDIC year 13/14. Logistic regression models were used to calculate the odds of incident CAN by DCCT treatment group after adjustment for DCCT baseline covariates, duration in the DCCT, and quantitative autonomic measures at DCCT closeout. In EDIC year 13/14, the prevalence of CAN using the DCCT composite definition was significantly lower in the former intensive group versus the former conventional group (28.9% versus 35.2%; P=0.018). Adjusted R-R variation was significantly greater in the former DCCT intensive versus the former conventional group (29.9 versus 25.9; P<0.001). Prior DCCT intensive therapy reduced the risks of incident CAN by 31% (odds ratio, 0.69; 95% confidence interval, 0.51 to 0.93) and of incident abnormal R-R variation by 30% (odds ratio, 0.70; 95% confidence interval, 0.51 to 0.96) in EDIC year 13/14.

Conclusions— Although CAN prevalence increased in both groups, the incidence was significantly lower in the former intensive group compared with the former conventional group. The benefits of former intensive therapy extend to measures of CAN up to 14 years after DCCT closeout.


 

CLINICAL PERSPECTIVE


Related Articles:

Circulation: Clinical Summaries
Circulation 2009 119: 2861-2862. [Extract] [Full Text]

Metabolic Memory in the Autonomic Neuropathy of Diabetes: Implications for Pathogenesis and Patient Care
Nishi Chaturvedi
Circulation 2009 119: 2865-2867. [Extract] [Full Text]



This article has been cited by other articles:


Home page
CirculationHome page
S. Stern and S. Sclarowsky
The ECG in Diabetes Mellitus
Circulation, October 20, 2009; 120(16): 1633 - 1636.
[Full Text] [PDF]


Home page
CirculationHome page
N. Chaturvedi
Metabolic Memory in the Autonomic Neuropathy of Diabetes: Implications for Pathogenesis and Patient Care
Circulation, June 9, 2009; 119(22): 2865 - 2867.
[Full Text] [PDF]